Application of the Stanford Biodesign Framework in Healthcare Innovation Training and Commercialization of Market Appropriate Products: A Scoping Review
Abstract The Stanford Biodesign needs-centric framework can guide healthcare innovators to successfully adopt the ‘Identify, Invent and Implement’ framework and develop new healthcare innovations products to address patients’ needs. This scoping review explored the application of the Stanford Biodesign framework for healthcare innovation training and the development of novel healthcare innovative products. Seven electronic databases were searched from their respective inception dates till April 2023: PubMed, Embase, CINAHL, PsycINFO, Web of Science, Scopus, ProQuest Dissertations, and Theses Global. This review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews and was guided by the Arksey and O’Malley’s scoping review framework. Findings were analyzed using Braun and Clarke’s thematic analysis framework. Three themes and eight subthemes were identified from the 26 included articles. The main themes are: (1) Making a mark on healthcare innovation, (2) Secrets behind success, and (3) The next steps. The Stanford Biodesign framework guided healthcare innovation teams to develop new medical products and achieve better patient health outcomes through the induction of training programs and the development of novel products. Training programs adopting the Stanford Biodesign approach were found to be successful in improving trainees’ entrepreneurship, innovation, and leadership skills and should continue to be promoted. To aid innovators in commercializing their newly developed medical products, additional support such as securing funds for early start-up companies, involving clinicians and users in product testing and validation, and establishing new guidelines and protocols for the new healthcare products would be needed..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Journal of medical systems - 48(2024), 1 vom: 22. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chua, Joelle Yan Xin [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Biodesign |
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s10916-024-02067-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055604943 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055604943 | ||
| 003 | DE-627 | ||
| 005 | 20240423064651.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240423s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10916-024-02067-x |2 doi | |
| 035 | |a (DE-627)SPR055604943 | ||
| 035 | |a (SPR)s10916-024-02067-x-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Chua, Joelle Yan Xin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of the Stanford Biodesign Framework in Healthcare Innovation Training and Commercialization of Market Appropriate Products: A Scoping Review |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract The Stanford Biodesign needs-centric framework can guide healthcare innovators to successfully adopt the ‘Identify, Invent and Implement’ framework and develop new healthcare innovations products to address patients’ needs. This scoping review explored the application of the Stanford Biodesign framework for healthcare innovation training and the development of novel healthcare innovative products. Seven electronic databases were searched from their respective inception dates till April 2023: PubMed, Embase, CINAHL, PsycINFO, Web of Science, Scopus, ProQuest Dissertations, and Theses Global. This review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews and was guided by the Arksey and O’Malley’s scoping review framework. Findings were analyzed using Braun and Clarke’s thematic analysis framework. Three themes and eight subthemes were identified from the 26 included articles. The main themes are: (1) Making a mark on healthcare innovation, (2) Secrets behind success, and (3) The next steps. The Stanford Biodesign framework guided healthcare innovation teams to develop new medical products and achieve better patient health outcomes through the induction of training programs and the development of novel products. Training programs adopting the Stanford Biodesign approach were found to be successful in improving trainees’ entrepreneurship, innovation, and leadership skills and should continue to be promoted. To aid innovators in commercializing their newly developed medical products, additional support such as securing funds for early start-up companies, involving clinicians and users in product testing and validation, and establishing new guidelines and protocols for the new healthcare products would be needed. | ||
| 650 | 4 | |a Stanford biodesign |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Biodesign |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Healthcare innovation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Medical technology |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Review |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Kan, Enci Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Phin Peng |e verfasserin |4 aut | |
| 700 | 1 | |a Shorey, Shefaly |e verfasserin |0 (orcid)0000-0001-5583-2814 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical systems |d Springer US, 1977 |g 48(2024), 1 vom: 22. Apr. |w (DE-627)SPR014621533 |w (DE-600)2017001-4 |x 1573-689X |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2024 |g number:1 |g day:22 |g month:04 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10916-024-02067-x |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.00 |q VZ |
| 951 | |a AR | ||
| 952 | |d 48 |j 2024 |e 1 |b 22 |c 04 | ||